[Controversy over the use of hydroxyethyl starch solutions. Is the use of low molecular weight hydroxyethyl starch contraindicated?].
Servicio de Anestesiología y Reanimación, Hospital General Universitario de Elda Virgen de la Salud, Elda, Alicante, España. Electronic address: sanchez_cal@gva.es.
C A
CA
Sánchez
Servicio de Anestesiología y Reanimación, Hospital Universitario Ramón y Cajal, Madrid, España.
M S
MS
Asuero
D002986:Clinical Trials as Topic; D003102:Colloids; D000075202:Contraindications; D000077324:Crystalloid Solutions; D005440:Fluid Therapy; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects / Q000737:chemistry; D007552:Isotonic Solutions; D007674:Kidney Diseases / Q000139:chemically induced* / Q000517:prevention & control; D015201:Meta-Analysis as Topic; D008970:Molecular Weight; D010952:Plasma Substitutes / Q000009:adverse effects / Q000737:chemistry; D011183:Postoperative Complications / Q000139:chemically induced* / Q000517:prevention & control; D014883:Water-Electrolyte Imbalance / Q000517:prevention & control / Q000628:therapy
D003102:Colloids; D000077324:Crystalloid Solutions; D006895:Hydroxyethyl Starch Derivatives; D007552:Isotonic Solutions; D010952:Plasma Substitutes